KidneyCancer,kcsm – MashupMD

Mashup Score: 0

Explaining PROs From the TiNivo-2 Study in Advanced Renal Cell Carcinoma - 15 hour(s) ago

Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.

Source: www.curetoday.com

Categories: General Medicine News, Nursing

Tweet Tweets with this article
- cure_today
  
  Explaining PROs From the TiNivo-2 Study in Advanced Renal Cell Carcinoma @katy_beckermann @TNOncology #KidneyCancer #kcsm https://t.co/1iStMyEqQG

Mashup Score: 6

Nivolumab Plus Cabozantinib in Non–Clear Cell RCC - 10 month(s) ago

David A. Braun, MD, PhD, highlights recent data focused on nivolumab plus cabozantinib in patients with non–clear cell renal cell carcinoma.

Source: www.onclive.com

Categories: General Medicine News, Onc News and Journals

Tweet Tweets with this article
- OncLive
  
  .@BraunMDPhD, of @YaleCancer, highlights recent data focused on nivolumab plus cabozantinib in patients with non–clear cell renal cell carcinoma. #KidneyCancer #kcsm https://t.co/p7VcQwuDcv